This review shows that the role of
5-hydroxytryptamine (5-HT) in the regulation of nociception depends on the
5-HT receptor subtypes involved and on long-term functional changes in the
5-HT receptors. Stimulation of the
5-HT1 receptors, as well as of the 5-HT2 and 5-HT3 receptors, may reduce nociceptive sensitivity. In addition, activation of 5-HT2 and 5-HT3 receptors may also enhance nociceptive sensitivity. Up- or down-regulation of the
5-HT receptors may result in long-lasting changes, plasticity, in the
5-HT systems. Lesioning of
5-HT neurons induces
denervation supersensitivity to
5-HT, and prolonged stimulation of
5-HT receptors may produce subsensitivity to
5-HT. In the spinal cord
denervation supersensitivity to
5-HT may depend on reduced release of
substance P (SP). An increase in the release of SP, on the other hand, may reduce the effects of
5-HT receptor activation. Long-term treatment with
antidepressants which are used in clinical
pain therapy appears to up-regulate the
5-HT1 receptors and to down-regulate the 5-HT2 receptors.